Mark C. Wiggins, EVP Corporate and Business Development at BIOGEN IDEC INC. (BIIB), sold 18,750 shares at $64.00 ($1.2M) on 2007-08-27, disclosed to the SEC on 2007-08-29.
Scheduled sale ($1.2M) by EVP Corporate and Business Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ZGNX | BUY | 2020-03-24 | $51K | — | Filing → |
| TCON | BUY | 2020-01-24 | $20K | — | Filing → |
| ZGNX | SELL | 2019-08-12 | $313K | — | Filing → |